CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

Cantor Fitzgerald upgraded CVS Health (NYSE:CVS) to Overweight from Neutral and increased its 12-month per-share target to $71 from $62 on Wednesday after the managed care giant delivered ...

However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock soaring Wednesday.